Article on colorectal cancer in BBA – Reviews on Cancer
In January 2015, "Portrait of the PI3K/AKT pathway in colorectal cancer" authored by researchers at the K.G Jebsen Colorectal Cancer Research Centre was published in the journal Biochimica et Biophysica Acta (BBA) – Reviews on Cancer.
Portrait of the PI3K/AKT pathway in colorectal cancer
Cells sense, integrate information and communicate through molecular signaling networks. Within these networks, the PI3K/AKT pathway plays a critical role in controlling cell proliferation, differentiation and death. PI3K/AKT hyper-activation is observed with considerable frequency across many cancer types and is thus an attractive target for pharmacological inhibition. In their article, Danielsen, Eide and colleagues review PI3K/AKT aberrations at multiple molecular levels in colorectal cancer and summarize the influences specific changes might have on the patients’ prognosis and response to targeting therapy.
Latest publicationsBrunsell et al. 2019. High concordance and negative prognostic impact of RAS/BRAF/PIK3CA mutations in multiple resected colorectal liver metastases. Clin. Colorectal Cancer [Online ahead of print] Sveen et al. 2019. Predictive modeling in colorectal cancer: time to move beyond consensus molecular subtypes. Ann. Oncol. 30(11): 1682-1685 Miranda et al. 2019. Cancer stemness, intratumoral heterogeneity, and immune response across cancers. PNAS 116(18): 9020-9029 Burocziova et al. 2019. Truncated PPM1D impairs stem cell response to genotoxic stress and promotes growth of APC-deficient tumors in the mouse colon. Cell Death. Dis. 10(11): 818
Eilertsen et al. 2019. Technical differences between sequencing and microarray platforms impact transcriptomic subtyping of colorectal cancer. Cancer Lett. [Epub ahead of print] All publications